Home > Financial Ratios > PAR DRUGS AND CHEMICALS

PAR DRUGS AND CHEMICALS
Core EBITDA Growth

    Back to All Ratios
PAR DRUGS AND CHEMICALS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for PAR DRUGS AND CHEMICALS
Please provide your vote to see the results

PAR DRUGS AND CHEMICALS Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) -6.1125.0212.211.4669.70

What is the latest Core EBITDA Growth ratio of PAR DRUGS AND CHEMICALS ?

The latest Core EBITDA Growth ratio of PAR DRUGS AND CHEMICALS is -6.11 based on Mar2025 Standalone results.
Year Core EBITDA Growth
Mar2025-6.11
Mar202425.02
Mar202312.21
Mar20221.46
Mar202169.70

How is Core EBITDA Growth of PAR DRUGS AND CHEMICALS Trending?

Years Core EBITDA Growth % Change
Mar2025 -6.11
Negative
Mar2024 25.02
104.91
Mar2023 12.21
736.30
Mar2022 1.46
-97.91
Mar2021 69.7 -

Other Financial Ratios of PAR DRUGS AND CHEMICALS


Compare Core EBITDA Growth ratio of peers of PAR DRUGS AND CHEMICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PAR DRUGS AND CHEMICALS ₹134.7 Cr -5.2% -13.9% 7.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹422,283.0 Cr 0.1% -5% 5.4% Stock Analytics
DIVIS LABORATORIES ₹244,762.0 Cr -1.7% 0.2% 39.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹173,448.0 Cr -2.5% -5.5% 30.2% Stock Analytics
CIPLA ₹107,043.0 Cr 0.9% -2.6% -14.6% Stock Analytics
DR REDDYS LABORATORIES ₹102,820.0 Cr 0.1% 7.6% -3.5% Stock Analytics


PAR DRUGS AND CHEMICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
PAR DRUGS AND CHEMICALS

-5.2%

-13.9%

7.5%

SENSEX

3.1%

1%

-9.1%


You may also like the below Video Courses